Theme Zones
Curated US-stock zones by value-chain layer and investment theme. Each zone maps a theme's public companies layer by layer, with the supply-chain chokepoints flagged. Curated structure; live delayed prices. Not investment advice.
The AI Stack
Jensen's five-layer cake — Energy → Chips → Infrastructure → Models → Applications
The AI build-out, layer by layer — from the power that feeds it, to the chips that compute it, to the models and apps that capture the value. Each layer's key public companies, with the supply-chain chokepoints flagged. Curated structure; live delayed prices from public data. Not investment advice.
Launch & Space
Launch · satellites · defense-space primes · eVTOL
The space economy across four sub-themes — launch & infrastructure, satellites & direct-to-device, defense-space primes, and eVTOL air mobility. The defense primes are the quality anchors; many new-space names are recent IPOs or pre-revenue (flagged). Curated structure; live delayed prices. Not investment advice.
Applied AI & Software
Where the enterprise AI budget gets spent
The application layer that captures the value of the AI build-out — enterprise software companies winning a growing share of the AI budget. (A standalone, value-capture angle on the same names in the AI flagship's Applications layer.) Curated structure; live delayed prices. Not investment advice.
GLP-1 & Obesity
The profitable obesity-drug duopoly + the oral challenger
The obesity / GLP-1 drug wave — the most fundamentally-grounded 10x theme, anchored by two profitable mega-cap leaders with real, large revenue today, plus a high-risk clinical-stage challenger. Curated structure; live delayed prices. Not investment advice.
Med-Tech & Surgical Robotics
Robotic surgery + the device majors riding it
Medical-device leaders with a robotics + AI tailwind — razor-and-blade surgical platforms and diversified device majors. More fundamentally-grounded than the speculative themes: profitable, durable compounders. Curated structure; live delayed prices. Not investment advice.
Genomics & Gene Editing
SpeculativeCRISPR editors + AI drug discovery — clinical-stage, binary readouts
Gene editing + computational/AI drug discovery — mostly clinical-stage, pre-revenue names whose value turns on binary trial readouts, anchored by one profitable, de-risked franchise. Curated structure; live delayed prices. Not investment advice.
Quantum Computing
SpeculativeThe pure-play lottery tickets + the de-risked big-tech option
Quantum computing — the highest-risk/highest-reward theme here. The pure-plays trade on extreme multiples with minimal revenue and headline-driven swings; the real, profitable exposure is an embedded option inside mega-caps. Curated structure; live delayed prices. Not investment advice.